Modulation of Adhesion Molecules by Cholesterol‐Lowering Therapy in Mononuclear Cells from Hypercholesterolemic Patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1755-5922|33|4|168-176

ISSN： 1755-5914

Source： CARDIOVASCULAR THERAPEUTICS (ELECTRONIC), Vol.33, Iss.4, 2015-08, pp. : 168-176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pleiotropic Effects and Cholesterol-Lowering Therapy

By  

Cardiology, Vol. 112, Iss. 1, 2008-06 ,pp. : 4-12

Karger

Access to resources Recommend Favorite

Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy

By Mikhailidis D. P.   Sibbring G. C.   Ballantyne C. M.   Davies G. M.   Catapano A. L.  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 2009-2026

Informa Healthcare

Access to resources Recommend Favorite

Long-Term Hemostatic Effects of Cholesterol-Lowering Therapy with Atorvastatin

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 33, Iss. 2, 2003-11 ,pp. : 84-87

Karger

Access to resources Recommend Favorite

Underutilization of Measurement of Serum Low‐Density Lipoprotein Cholesterol Levels and of Lipid‐Lowering Therapy in Older Patients with Manifest Atherosclerotic Disease

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 46, Iss. 9, 1998-09 ,pp. : 1128-1131

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cholesterol-lowering drugs and Alzheimer’’s disease

By Eckert Gunter P   Müüller Walter E   Wood W Gibson  

Future Lipidology, Vol. 2, Iss. 4, 2007-08 ,pp. : 423-432

Future Medicine

Access to resources Recommend Favorite